Ranked after the close on October 30, 2026
Medical Devices stocks
Medical Devices ranks #22 of 140 industry groups, one of the market's strongest groups, with a median 6-month return of +14% across its 40 US stocks above $1B (sector: Healthcare).
#22group rank of 140
+14%median, 6 months
40stocks above $1B
0in the top 50
Medical Devices stocks ranked
| # | Stock | Market cap | Off high | Comp | EPS | RS |
|---|---|---|---|---|---|---|
| 1 | AXGNAxoGen, Inc. | $2.9B | 6.7% | |||
| 2 | GKOSGlaukos Corporation | $14.1B | 4.5% | |||
| 3 | LIVNLivaNova PLC | $4.4B | 7.9% | |||
| 4 | DXCMDexCom, Inc. | $30.7B | 11.1% | |||
| 5 | BIOBio-Rad Laboratories, Inc. | $10.0B | 6.1% | |||
| 6 | MDTMedtronic plc. | $123.5B | 9.2% | |||
| 7 | INSPInspire Medical Systems, Inc. | $2.0B | 53.7% | |||
| 8 | HAEHaemonetics Corporation | $5.4B | 3.3% | |||
| 9 | UFPTUFP Technologies, Inc. | $2.2B | 16.0% | |||
| 10 | ZBHZimmer Biomet Holdings, Inc. | $18.0B | 8.9% | |||
| 11 | BIO-BBio-Rad Laboratories, Inc. | $10.2B | 0.0% | |||
| 12 | CBLLCeriBell, Inc. | $1.0B | 5.7% | |||
| 13 | PENPenumbra, Inc. | $12.6B | 12.0% | |||
| 14 | BFLYButterfly Network, Inc. | $1.7B | 37.4% | |||
| 15 | GEHCGE HealthCare Technologies Inc. | $34.6B | 14.7% | |||
| 16 | PODDInsulet Corporation | $10.4B | 57.8% | |||
| 17 | EWEdwards Lifesciences Corporatio | $53.0B | 4.4% | |||
| 18 | ITGRInteger Holdings Corporation | $4.3B | 0.2% | |||
| 19 | PHGKoninklijke Philips N.V. NY Reg | $26.3B | 19.5% | |||
| 20 | LMRILumexa Imaging Holdings, Inc. | $1.1B | 41.3% | |||
| 21 | TXG10x Genomics, Inc. | $9.1B | 31.8% | |||
| 22 | STESTERIS plc (Ireland) | $22.1B | 15.7% | |||
| 23 | ALMRAlamar Biosciences, Inc. | $2.1B | 22.7% | |||
| 24 | NEOGNeogen Corporation | $2.6B | 17.1% | |||
| 25 | SNNSmith & Nephew SNATS, Inc. | $12.4B | 19.9% | |||
| 26 | CNMDCONMED Corporation | $1.3B | 17.5% | |||
| 27 | GMEDGlobus Medical, Inc. | $10.5B | 23.0% | |||
| 28 | BRKRBruker Corporation | $8.7B | 14.8% | |||
| 29 | TNDMTandem Diabetes Care, Inc. | $1.3B | 35.5% | |||
| 30 | SYKStryker Corporation | $111.1B | 25.0% | |||
| 31 | IRTCiRhythm Holdings, Inc. | $4.1B | 41.8% | |||
| 32 | ABTAbbott Laboratories | $185.0B | 19.6% | |||
| 33 | NVCRNovoCure Limited | $1.5B | 38.7% | |||
| 34 | TMDXTransMedics Group, Inc. | $2.3B | 57.7% | |||
| 35 | ESTAEstablishment Labs Holdings Inc | $1.9B | 36.0% | |||
| 36 | BSXBoston Scientific Corporation | $60.8B | 60.3% | |||
| 37 | ENOVEnovis Corporation | $1.1B | 38.6% | |||
| 38 | ATECAlphatec Holdings, Inc. | $1.1B | 69.8% | |||
| 39 | PRCTPROCEPT BioRobotics Corporation | $1.1B | 49.6% | |||
| 40 | AORTArtivion, Inc. | $1.1B | 53.2% |
In order of their Comp rating. The ratings themselves, and the same day's ranking, are for members. Sign in or start for €6.99 a month.
See every rating for €6.99 a month
Nearby in the ranking
- Packaging & Containers #20
- Drug Manufacturers - Specialty & Generic #21
- Utilities - Regulated Water #23
- Information Technology Services #24